Association between lipoprotein (a) levels and cardiac allograft vasculopathy among heart transplant recipients: Insights from a single-center cohort.

Median serum Lp(a) concentration was 40 nmol/L; 62 patients (23%) had Lp(a) >125 nmol/L.

Median Lp(a) levels did not significantly differ between patients with cardiac allograft vasculopathy 0-1 and patients with cardiac allograft vasculopathy 2-3 (median 37 vs 55 nmol/L, P = .408).

Elevated Lp(a) concentrations (>75, >125, >200 nmol/L) did not show significant correlation with either cardiac allograft vasculopathy 2-3 nor with cardiac allograft vasculopathy 1-2-3.